A novel proteotoxic combination therapy for EGFR+ and HER2+ cancers-Reference-Cited by-同舟云学术

A novel proteotoxic combination therapy for EGFR+ and HER2+ cancers

Published:2019-02-04 Issue:22 Volume:38 Page:4264-4282
ISSN:0950-9232
Container-title:Oncogene
language:en
Short-container-title:Oncogene

Author:

Wang Mengxiong,Ferreira Renan B.,Law Mary E.,Davis Bradley J.,Yaaghubi Elham,Ghilardi Amanda F.,Sharma Abhisheak,Avery Bonnie A.,Rodriguez Edgardo,Chiang Chi-Wu,Narayan Satya,Heldermon Coy D.,Castellano Ronald K.,Law Brian K.^ORCID

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Genetics,Molecular Biology

Link

http://www.nature.com/articles/s41388-019-0717-6.pdf

Reference43 articles.

1. Chlebowski RT, Manson JE, Anderson GL, Cauley JA, Aragaki AK, Stefanick ML, et al. Estrogen plus progestin and breast cancer incidence and mortality in the Women’s Health Initiative Observational Study. J Natl Cancer Inst. 2013;105:526–35.

2. Obeng EA, Carlson LM, Gutman DM, Harrington WJ Jr., Lee KP, Boise LH. Proteasome inhibitors induce a terminal unfolded protein response in multiple myeloma cells. Blood. 2006;107:4907–16.

3. Wang M, Law ME, Castellano RK, Law BK. The unfolded protein response as a target for anticancer therapeutics. Crit Rev Oncol/Hematol. 2018;127:66–79.

4. Stocki P, Chapman DC, Beach LA, Williams DB. Depletion of cyclophilins B and C leads to dysregulation of endoplasmic reticulum redox homeostasis. J Biol Chem. 2014;289:23086–96.

5. Dunyak BM, Gestwicki JE. Peptidyl-proline isomerases (PPIases): targets for natural products and natural product-inspired compounds. J Med Chem. 2016;59:9622–44.

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. DR5 disulfide bonding as a sensor and effector of protein folding stress;2024-03-07

2. Cyclosporine A enhanced the cytotoxicity of immunotoxin to the HER-2-overexpressing SK-OV-3 cells;2023-07-26

3. Anticancer Agents Derived from Cyclic Thiosulfonates: Structure‐Reactivity and Structure‐Activity Relationships;ChemMedChem;2022-05-23

4. Inhibitors of ERp44, PDIA1, and AGR2 induce disulfide-mediated oligomerization of Death Receptors 4 and 5 and cancer cell death;Cancer Letters;2022-05

5. Repurposing Tranexamic Acid as an Anticancer Agent;Frontiers in Pharmacology;2022-01-13